{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:35:25Z","timestamp":1791056125204,"version":"4.1.0"},"reference-count":60,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Interleukin-10 (IL-10) is thought to promote intracellular infection, including human visceral leishmaniasis, by disabling Th1 cell-type responses and\/or deactivating parasitized tissue macrophages. To develop a rationale for IL-10 inhibition as treatment in visceral infection, Th1 cytokine-driven responses were characterized in<jats:italic>Leishmania donovani<\/jats:italic>-infected BALB\/c mice in which IL-10 was absent or overexpressed or its receptor (IL-10R) was blockaded. IL-10 knockout and normal mice treated prophylactically with anti-IL-10R demonstrated accelerated granuloma assembly and rapid parasite killing without untoward tissue inflammation; IL-12 and gamma interferon mRNA expression, inducible nitric oxide synthase reactivity, and responsiveness to antimony chemotherapy were also enhanced in knockout mice. In IL-10 transgenic mice, parasite replication was unrestrained, and except for antimony responsiveness, measured Th1 cell-dependent events were all initially impaired. Despite subsequent granuloma assembly, high-level infection persisted, and antimony-treated transgenic mice also relapsed. In normal mice with established infection, anti-IL-10R treatment was remarkably active, inducing near-cure by itself and synergism with antimony. IL-10's deactivating effects regulate outcome in experimental visceral leishmaniasis, and IL-10R blockade represents a potential immuno- and\/or immunochemotherapeutic approach in this infection.<\/jats:p>","DOI":"10.1128\/iai.70.11.6284-6293.2002","type":"journal-article","created":{"date-parts":[[2002,10,15]],"date-time":"2002-10-15T02:36:49Z","timestamp":1034649409000},"page":"6284-6293","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":203,"title":["Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy"],"prefix":"10.1128","volume":"70","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[{"name":"Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Mauze","sequence":"additional","affiliation":[{"name":"Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Freeman","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre L.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Pathology, New York University School of Medicine, New York, New York 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilla","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Coffman","sequence":"additional","affiliation":[{"name":"Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.7.995"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90314-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.13"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.413"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2000.0694"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.6954-6961.2000"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.10.1497"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1499-1507.2001"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.6.1549"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.10.1529"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.4.986"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.1999.00224.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.4422-4426.1992"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.7.4561-4571.2001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46651998000100007"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1996.0105"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N"},{"key":"e_1_3_2_19_2","first-page":"64","volume":"111","year":"1998","unstructured":"Gassim, S., A. M. El-Hassan, E. A. G. Khalil, A. Ismail, A. M. Y. Kadarn, A. Kharazmi, and T. G. Theander. 1998. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol.111:64-69.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116570"},{"key":"e_1_3_2_21_2","first-page":"1723","volume":"62","year":"1999","unstructured":"Groux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Aantonenko, S. Hurst, T. McNeil, M. Bigler, M-G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol.62:1723-1729.","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.2.1141"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116372"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/517679"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80068-P"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.1.127-132.1997"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.167.6.1927"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.1.18-27.1998"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.5.2135-2142.1998"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.3.1058-1063.1994"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(00)90078-X"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.8.2185-2197.2001"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4049\/jimmunol.151.2.929","volume":"151","year":"1993","unstructured":"Murray, H. W., G. D. Miralles, M. Y. Stoeckle, and D. F. McDermott. 1993. Role and effect of interleukin-2 in experimental visceral leishmaniasis. J. Immunol.151:929-934.","journal-title":"J. Immunol."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117767"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/315890"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","volume":"82","year":"2001","unstructured":"Murray, H. W. 2001. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol.82:249-276.","journal-title":"Int. J. Exp. Pathol."},{"key":"e_1_3_2_39_2","unstructured":"Murray H. W. 1999. Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis p. 977-994. In J. Gallin R. Synderman D. Fearon B. Haynes and C. Nathan (ed.) Inflammation: basic principles and clinical correlates 3rd ed. Lippincott-Raven Philadelphia Pa."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.288-293.2000"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.11.6289-6293.2000"},{"key":"e_1_3_2_42_2","first-page":"1254","volume":"83","year":"1989","unstructured":"Murray, H. W., M. J. Oca, A. M. Granger, and R. D. Schreiber. 1989. Successful response to chemotherapy in experimental visceral leishmaniasis: requirement for T cells and effect of lymphokines. J. Clin. Investig.83:1254-1259.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.5.973"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.867"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.741"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.11.6294-6299.2000"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4049\/jimmunol.158.1.315","volume":"158","year":"1997","unstructured":"Murray, P. J., L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young. 1997. T-cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol.158:315-321.","journal-title":"J. Immunol."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(96)10078-8"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230926"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1086\/319869"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/314635"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200003)30:3<834::AID-IMMU834>3.0.CO;2-9"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4894-4899.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.10.6323"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/516526"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1627"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.522"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.7.1231"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","volume":"153","year":"1994","unstructured":"Tumang, M., C. Keogh, L. L. Moldawer, R. Teitelbaum, J. Hariprashad, and H. W. Murray. 1994. The role and effect of tumor necrosis factor-alpha in experimental visceral leishmaniasis. J. Immunol.153:768-775.","journal-title":"J. Immunol."},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.156.6.2231","volume":"156","year":"1996","unstructured":"Wilson, M. E., M. Sandor, A. M. Blum, B. M. Young, A. Metwali, D. Elliott, R. G. Lynch, and J. V. Weinstick. 1996. Local suppression of IFN-\u03b3 in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol.156:2231-2239.","journal-title":"J. Immunol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.161.11.6148","volume":"161","year":"1998","unstructured":"Wilson, M. E., B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan. 1998. The importance of transforming growth factor beta-\u03b2 in murine visceral leishmaniasis. J. Immunol.161:6148-6155.","journal-title":"J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.11.6284-6293.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.11.6284-6293.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T08:53:20Z","timestamp":1704617600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.11.6284-6293.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1128\/IAI.70.11.6284-6293.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.11.6284-6293.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2002-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}